Infinity Bio, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Aug 20, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 11, 2025 · D | Aug 20, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $5,000,000 | $7,000,000 | $2,000,000 |
| Reported amount sold | $2,000,000 | $5,000,000 | $3,000,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001982572-25-000001 · Later SEC source: 0001982572-25-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $7,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $5,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
BFI INFINITY LTD.
medium CRD 801-72602
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- PTX Capital Fund III LP · CIK 2126445
Form D filings (2)
-
0001982572-25-000003D · Aug 20, 2025 · Other Health CareOffering: $7,000,000Sold: $5,000,000
Compared with 0001982572-25-000001:
- Reported offering amount: $5,000,000 → $7,000,000
- Reported amount sold: $2,000,000 → $5,000,000
-
0001982572-25-000001D · Mar 11, 2025 · BiotechnologyOffering: $5,000,000Sold: $2,000,000